US-based medical device firm NuVasive has acquired interbody implants provider Vertera Spine, expanding its advanced materials science portfolio.

Financial details of the deal have not been disclosed.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Vertera uses patented porous polyetheretherketone (PEEK) technology to develop and commercialise implants for spinal fusion.

Using a specific processing method to retain strength and durability, the technology offers a three-dimensional porous PEEK architecture that is said to aid the stimulation of bone ingrowth in patients who have undergone spinal fusion procedures.

The acquisition will now allow NuVasive to deliver porous interbody technology across PEEK and titanium materials to serve different needs and preferences of surgeons for interbody implants.

“This helps to create more predictable, improved outcomes for patients undergoing spine surgery.”

NuVasive chairman and CEO Gregory Lucier said: “With the addition of porous PEEK technology, NuVasive takes the next step in building out its advanced materials science technology focused on delivering the highest level of scientifically driven properties for best spinal fusion rates, including porosity, visualisation, surface, and structure.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“This, in turn, helps to create more predictable, improved outcomes for patients undergoing spine surgery.”

The firm plans to add Vertera’s products to its commercial offerings and further use the porous PEEK technology during development of new products.

Vertera’s current interbody product portfolio includes the US Food and Drug Administration (FDA) cleared COHERE cervical interbody fusion device and COALESCE device that is designed for anterior, transforaminal, posterior and lateral lumbar interbody fusion procedures.

The firm is planning to secure extensions of COALESCE for posterior and transforaminal lumbar interbody fusion.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact